Bayer & Monsanto v. Duffy: $549,500 Judgment for Willful GMO Seed Infringement
Bayer AG and Monsanto Technology LLC secured summary judgment against Missouri farmer Caleb Duffy for knowingly infringing two GM soybean patents and breaching Technology Stewardship Agreements across three crop years. The court awarded $549,500 in liquidated damages and imposed a permanent injunction — a textbook enforcement action illustrating the legal exposure facing growers who save or replant patented biotech seed.
Monsanto’s Xtend Seed IP Enforcement Reaches Missouri Grower
Filed on 25 January 2023 in the Eastern District of Missouri before Judge John A. Ross, this case pits agricultural biotech giants Bayer AG and Monsanto Technology LLC against individual soybean farmer Caleb Duffy. The dispute centres on two foundational patents: US7838729B2, covering soybean event MON89788 detection methods, and US9944945B2, covering chloroplast transit peptides used to target dicamba monooxygenase (DMO) — core intellectual property underpinning Monsanto’s Xtend crop system. Plaintiffs alleged Duffy saved, planted, and replanted patented seed across the 2020, 2021, and 2022 growing seasons without authorisation, while also applying unapproved dicamba formulations past permitted deadlines.
The case closed on 18 April 2025 via summary judgment in favour of Bayer CropScience LP and Monsanto Technology LLC — meaning the court found no genuine dispute of material fact requiring trial. Duffy was found liable for both knowing and wilful patent infringement and for breaching Technology Stewardship Agreements (TSAs) covering all three crop years. The judgment quantified harm as $549,500 in liquidated damages, consistent with contractual damages provisions common in seed licensing. A permanent injunction was also entered, barring Duffy from any future use, saving, selling, or transfer of seed containing plaintiffs’ patented biotechnologies without express written permission.
An 814-day duration is consistent with a case that progressed to summary judgment without a full trial — suggesting the evidentiary record was sufficiently clear-cut to foreclose factual dispute. The wilfulness finding is commercially significant: it opens the door to enhanced damages under 35 U.S.C. § 284, though the judgment here appears premised on contractual liquidated damages rather than judicially enhanced patent damages. The public record does not disclose whether Duffy has appealed or whether any payment terms were negotiated post-judgment.
Filing to Judgment on the merits for Plaintiff in 814 days
814 days from filing to judgment — typical for a district court summary judgment case with no trial
Summary judgment for Bayer & Monsanto: what the ruling means for both parties
Summary judgment on willful infringement — no trial required
The court entered summary judgment, meaning plaintiffs demonstrated that no genuine issue of material fact existed regarding infringement or breach of the TSAs. A wilfulness finding at summary judgment is notable: it indicates Duffy’s conduct was sufficiently documented — likely through seed purchase records, field inspections, and TSA records — that the court could resolve liability without a jury. Wilful infringement typically supports enhanced damages under 35 U.S.C. § 284.
Summary judgment — no trialFull relief: damages, injunction, and wilfulness on record
Bayer and Monsanto achieved the maximum available relief at this stage: a liquidated damages award of $549,500 grounded in TSA terms, a permanent injunction preventing any further use of patented seed technologies, and a court-endorsed wilfulness finding. The injunction is particularly powerful — it extends to all Plaintiffs’ patented biotechnologies, not just the specific varieties used in 2020–2022, reinforcing Monsanto’s ability to enforce seed IP broadly against this defendant.
Full injunctive + monetary reliefPermanent injunction and six-figure damages liability for seed saving
Duffy faces a $549,500 liquidated damages judgment and a court-ordered permanent injunction barring future use of Plaintiffs’ biotech seed without written permission. The injunction also specifically prohibits post-deadline dicamba applications to Xtend crops. For an individual farmer, this represents substantial financial and operational exposure. The wilfulness finding on record would complicate any future appeal on damages quantum. No settlement or appeal information is publicly disclosed.
Six-figure liability + permanent banA precedent reinforcing Monsanto’s seed enforcement playbook
This judgment is consistent with Monsanto’s decades-long strategy of using TSAs as both a licensing tool and an enforcement mechanism. The liquidated damages clause in the TSA effectively pre-quantifies harm, making summary judgment more attainable. For the broader agri-biotech sector, the case signals that wilful seed saving — even by individual growers — remains vigorously prosecuted. R&D teams developing competing biotech traits should treat US7838729B2 and US9944945B2 as live, actively enforced IP.
Active IP enforcement signalFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Bayer AG | Company | Agricultural biotech conglomerate — holder of US7838729B2 and US9944945B2Search in Eureka ↗ |
| Co-Plaintiff | Monsanto Technology, LLC | Company | Search in Eureka ↗ |
| Defendant | Caleb Duffy | Individual | Individual Missouri soybean farmer alleged to have saved and replanted patented Xtend seedSearch in Eureka ↗ |
| Plaintiff counsel | Anthony F. Blum | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Daniel C. Cox | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Jeffrey A. Masson | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Matthew S. Bober | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff law firm | Thompson Coburn LLP (St Louis) | Law Firm | Representing Bayer AGSearch in Eureka ↗ |
| Defendant counsel | Wendell L. Hoskins , II | Attorney | Counsel for Caleb DuffySearch in Eureka ↗ |
| Defendant law firm | Hoskins Law Office | Law Firm | Representing Caleb DuffySearch in Eureka ↗ |
| Presiding judge | Judge John A. Ross | Judge | Missouri Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The verdict’s explicit wilfulness language — ‘knowingly and willfully infringing’ — carries weight beyond mere liability. Under 35 U.S.C. § 284, wilful infringement allows courts to award up to treble damages, though the judgment here appears premised on contractual liquidated damages rather than judicially enhanced patent damages. The dual basis of liability (patent infringement and TSA breach) is strategically significant: it gives Bayer and Monsanto parallel enforcement tracks. The permanent injunction’s breadth, covering all patented biotechnologies rather than only those at issue, suggests the court accepted plaintiffs’ framing of Duffy as a systemic rather than incidental infringer.
US7838729B2 & US9944945B2 — Xtend Soybean Biotechnology Patents
US7838729B2 (application no. US11/758659) covers soybean event MON89788 — the specific transgenic insertion event that defines Roundup Ready 2 Yield soybeans — and methods for its detection. US9944945B2 (application no. US14/539923) protects chloroplast transit peptides engineered to efficiently deliver dicamba monooxygenase (DMO) into plant plastids, enabling dicamba herbicide tolerance in Xtend crops. Together, these patents protect both the genetic identity of the soybean event and the molecular machinery enabling the herbicide-tolerance trait — covering detection, expression, and use.
For the agri-biotech sector, these two patents represent complementary layers of protection: one controls the ability to identify the patented event (enabling enforcement against seed savers), while the other controls the functional herbicide-tolerance mechanism. Any competitor seeking to develop dicamba-tolerant soybeans or detect the MON89788 event must navigate both assets. The court’s willingness to enter summary judgment on both simultaneously confirms that the patents are enforceable in combination and that Bayer/Monsanto’s enforcement infrastructure — including TSAs and field inspections — is sufficiently robust to meet the evidentiary standard without trial.
Should you run an FTO against US7838729B2 and US9944945B2?
Any R&D team or agri-biotech company developing herbicide-tolerant soybean traits, GM event detection assays, or chloroplast-targeted enzyme delivery systems should treat these patents as high-priority FTO targets. The Duffy judgment confirms both patents are actively enforced and litigation-ready. Seed companies licensing Xtend technology, as well as competitors developing alternative DMO-based or plastid-targeting approaches, face direct infringement exposure if their products overlap with the claims of either patent.
PatSnap Eureka’s FTO Search Agent can map the full claim scope of US7838729B2 and US9944945B2 against your product pipeline, flag design-around opportunities, and surface the broader Xtend patent family — including continuation and divisional applications that may extend protection beyond these two grants. Eureka’s prior art and validity analysis tools also let you assess whether either patent presents IPR or ex parte reexamination opportunities before committing to a design-around or licensing strategy.
Run a freedom-to-operate analysis on US7838729B2 to assess your product’s exposure
Run FTO in Eureka →Similar GM Seed Patent Enforcement Cases in U.S. District Courts
Explore comparable Monsanto and Bayer biotech seed patent infringement cases filed in U.S. district courts involving TSA breaches and GMO trait enforcement.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Chloroplast transit peptides for efficient targeting of DMO and uses thereof-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedBayer AG’s broader IP enforcement history
Bayer AG’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the agri-biotech IP enforcement landscape
Bayer and Monsanto’s summary judgment win reinforces the potency of TSA-backed patent enforcement against downstream seed users.
TSA liquidated damages clauses make summary judgment more achievable
By embedding liquidated damages in Technology Stewardship Agreements, Monsanto pre-establishes the quantum of harm — eliminating a key factual dispute that would otherwise require trial. Companies licensing biotech IP through click-wrap or paper TSAs should audit whether their clauses are sufficiently specific to survive summary judgment scrutiny.
Wilfulness findings at summary judgment set a high bar for growers
A wilfulness finding without trial signals that the evidentiary record — likely including purchase receipts, field inspection reports, and TSA acknowledgment logs — was unambiguous. Seed companies should ensure their audit and compliance programmes generate this level of documentary evidence as a matter of routine enforcement infrastructure.
Both ‘729 and ‘945 patents remain actively enforced — FTO exposure is real
The court’s enforcement of US7838729B2 (MON89788 event detection) and US9944945B2 (chloroplast transit peptide/DMO targeting) confirms both patents are live and litigation-ready. Any competitor developing herbicide-tolerant soybean traits using similar event detection or plastid-targeting approaches faces direct infringement risk without a clear design-around.
Permanent injunction scope extends beyond 2020–2022 varieties — watch for future actions
The injunction is not limited to the specific seed varieties used during the three crop years at issue. It bars use of any seed containing Plaintiffs’ patented biotechnologies — suggesting enforcement reach that could extend to successor varieties. Licensees and growers operating under Bayer/Monsanto TSAs should conduct annual compliance reviews.
Bayer v Caleb — key questions answered
The Eastern District of Missouri entered summary judgment for Bayer CropScience LP and Monsanto Technology LLC on 18 April 2025. The court found Caleb Duffy knowingly and wilfully infringed US7838729B2 and US9944945B2 and breached Technology Stewardship Agreements for 2020, 2021, and 2022. The judgment awarded $549,500 in liquidated damages and imposed a permanent injunction against future use of plaintiffs’ patented biotechnologies.
Two patents were asserted: US7838729B2, covering soybean event MON89788 and detection methods (application US11/758659), and US9944945B2, covering chloroplast transit peptides for efficient targeting of dicamba monooxygenase (DMO) in plants (application US14/539923). These patents underpin Monsanto’s Roundup Ready 2 Yield and Xtend soybean product lines.
A TSA is a contract between a seed company and a grower that sets out permitted uses of patented seed — typically prohibiting seed saving, replanting, and off-label herbicide use. A breach provides a parallel contractual cause of action alongside patent infringement, and TSAs commonly include liquidated damages clauses that pre-quantify harm per violation. In this case, the TSA breach claim covering three crop years enabled the $549,500 liquidated damages award without requiring separate damages proof.
The permanent injunction bars Duffy from making, using, saving, planting, selling, offering to sell, importing, or transferring any soybean or other seed containing Plaintiffs’ patented biotechnologies without express written permission. It also separately prohibits applying unapproved formulations of dicamba-based herbicides to Xtend crops, including doing so after applicable deadlines. The scope extends beyond the varieties at issue in the three crop years litigated.
A wilfulness finding means the court concluded that the infringer acted with subjective knowledge that their conduct was infringing — typically demonstrated through documentary evidence rather than inference. At summary judgment, this means the record was clear enough to resolve the question without a jury. Wilful infringement is a prerequisite for enhanced damages under 35 U.S.C. § 284 (up to treble damages), and also supports awards of attorneys’ fees under § 285 in exceptional cases.
Monitor GM Crop Patent Enforcement Before It Affects Your Pipeline
This case confirms Bayer and Monsanto’s Xtend patents are litigation-active. Run an FTO against US7838729B2 and US9944945B2 with PatSnap Eureka, and set up alerts for new enforcement actions across the GM soybean IP landscape.
PatSnap Eureka searches patents and litigation data to answer instantly.